rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Bruno Jean-Marie Baillavoine

Director

Company insider

Files Form 4 as: Director, Cel-Sci.

In numbers

Trades disclosed
16
Buys
3
Sells
0
Bought
$29K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
22 Jun 2015
Last trade
14 Aug 2026
Last filed
17 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CVM Cel-SciDirector · Biotechnology · last 14 Aug 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Aug 2026filed 17 Aug 2026CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,100110,000 at $0.01filing
14 Aug 2026filed 17 Aug 2026CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,100110,000 at $0.01filing
28 Jul 2025filed 29 Jul 2025CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$404,000 at $0.01filing
19 Apr 2024filed 23 Apr 2024CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$64064,000 at $0.01filing
8 Aug 2023filed 10 Aug 2023CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$64064,000 at $0.01filing
13 Jun 2022filed 14 Jun 2022CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$64064,000 at $0.01filing
6 Jul 2021filed 7 Jul 2021CVM Cel-SciBiotechnologySEC FORM 4 Bought$10K1,250 at $8.00filing
14 May 2021filed 17 May 2021CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,280128,000 at $0.01filing
18 Nov 2020filed 18 Nov 2020CVM Cel-SciBiotechnologySEC FORM 4 Bought$9,416800 at $11.77filing
20 Apr 2020filed 20 Apr 2020CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,280128,000 at $0.01filing
26 Feb 2020filed 27 Feb 2020CVM Cel-SciBiotechnologySEC FORM 4 Bought$9,996923 at $10.83filing
11 Apr 2019filed 12 Apr 2019CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$1,600160,000 at $0.01filing
1 May 2018filed 3 May 2018CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$80080,000 at $0.01filing
28 Jul 2017filed 1 Aug 2017CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$20020,000 at $0.01filing
12 Jun 2017filed 30 Jun 2017CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A$757,500 at $0.01filing
22 Jun 2015filed 1 Jul 2015CVM Cel-Scioption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Geert R. KerstenChief Executive Officer · Chief Executive Officer at Cel Sci, filing Form 4 there in the last year
Patricia B. PrichepChief Financial Officer · Chief Financial Officer at Cel Sci, filing Form 4 there in the last year
Eyal TalorChief Scientific Officer · Chief Scientific Officer at Cel Sci, filing Form 4 there in the last year
John CiprianoSenior Vice President · Senior Vice President at Cel Sci, filing Form 4 there in the last year
Robert Eugene WatsonDirector · Director at Cel Sci, filing Form 4 there in the last year